Research Article
Macroscopic Portal Vein Thrombosis in HCC Patients
Table 1
Comparisons amongst HCC patients between portal vein thrombosis groups, in single MTD categories.
| | MTD<5.0 (cm) | | 5.0≤MTD≤10.0 (cm) | | MTD>10.0 (cm) | | Parameter | PVT(No) | PVT(Yes) | | PVT(No) | PVT(Yes) | | PVT(No) | PVT(Yes) | | | (n=701) | (n=112) (13.7%) | | (n=388) | (n=199) (33.9%) | | (n=84) | (n=109) (56.4%) | |
| | | | | | | | | | | Sex (M) (%) | 145 (79.32) | 88 (78.57) | 0.86∧ | 319 (82.22) | 164 (82.41) | 0.95 ∧ | 72 (85.71) | 96 (88.07) | 0.63 ∧ | Age (yr) | 61.55±11.04 | 61.59±11.53 | 0.98 | 63.86±10.95 | 61.24±11.88 | 0.005 | 63.89±12.52 | 60.69±13.68 | 0.08 | Cigarettes smoke (%) | 159 (44.04) | 32 (42.11) | 0.76 ∧ | 129 (60.85) | 79 (56.03) | 0.37 ∧ | 26 (55.32) | 32 (57.14) | 0.85 ∧ | Alcohol (%) | 63 (17.65) | 8 (11.11) | 0.17 ∧ | 27 (13.85) | 25 (18.12) | 0.29 ∧ | 7 (20.00) | 7 (12.07) | 0.30 ∧ | Child-Pugh (B&C) | | | 0.01 ∧ | | | <0.001 ∧ | | | 0.47 ∧ | A | 217 (39.19) | 18 (22.22) | | 138 (44.23) | 44 (26.04) | | 26 (35.14) | 23 (26.44) | | B | 212 (38.27) | 41 (50.62) | | 118 (37.82) | 70 (41.42) | | 28 (37.84) | 39 (44.83) | | C | 125 (22.56) | 22 (27.16) | | 56 (17.95) | 55 (32.54) | | 20 (27.03) | 25 (28.74) | | Cirrhosis (%) | 542 (79.47) | 88 (87.13) | 0.07 ∧ | 301 (77.98) | 168 (85.71) | 0.03 ∧ | 62 (73.81) | 81 (77.88) | 0.51 ∧ | Albumin (g/dL) | 3.15±0.76 | 2.95±0.76 | 0.02 | 3.11±0.75 | 2.97±0.71 | 0.07 | 3.04±0.74 | 3.00±0.63 | 0.60 | GGTP (U/L) | 148.07±186.14 | 143.42±134.30 | 0.41 | 147.47±153.36 | 210.61±206.48 | 0.0003 | 186.06±153.04 | 213.74±175.12 | 0.34 | AST (U/L) | 118.06±226.07 | 102.20±92.59 | 0.86 | 100.88±121.40 | 114.37±105.87 | 0.02 | 146.35±425.67 | 114.46±112.63 | 0.07 | ALKP (U/L) | 190.97±216.09 | 191.34±168.76 | 0.40 | 193.97±139.92 | 279.19±313.31 | 0.02 | 232.77±149.04 | 268.86±241.38 | 0.96 | Bilirubin (mg/dL) | 2.41±3.45 | 2.52±3.41 | 0.67 | 2.27±3.67 | 3.60±5.44 | 0.009 | 1.96±3.06 | 2.58±3.61 | 0.22 | Platelet counts (103/μL) | 139.16±85.58 | 141.80±90.29 | 0.92 | 161.86±89.36 | 180.04±108.38 | 0.10 | 226.94±141.19 | 227.79±127.74 | 0.63 | AFP (IU/mL) | 1774.84±13163.19 | 2722.60±8062.90 | <0.0001 | 3504.43±18586.15 | 10976.9±54278.4 | 0.0007 | 9395.0±29325.7 | 18393.3±55766.2 | 0.02 | MTD (cm) | 2.91±1.01 | 3.13±0.94 | 0.03 | 7.00±1.73 | 7.47±1.66 | 0.0004 | 14.29±3.56 | 14.24±3.17 | 0.91 | Nodules number (%) | | | 0.002 ∧ | | | <0.001 ∧ | | | <0.001 ∧ | Unifocal | 507 (72.53) | 62 (57.94) | | 271 (70.76) | 98 (50.52) | | 67 (79.76) | 55 (55.00) | | Multifocality (≥2) | 192 (27.47) | 45 (42.06) | | 112 (29.24) | 96 (49.48) | | 17 (20.24) | 45 (45.00) | | | | | | | | | | | |
|
|
All values: means ± standard deviation as continuous; Frequencies and percentage (%) as categorical. Wilcoxon rank-sum (Mann–Whitney) test; ∧ Chi-square test. GGTP, gamma glutamyl transpeptidase; ALKP, alkaline phosphatase; AFP, alpha-fetoprotein; MTD, maximum tumor diameter; PVT, portal vein thrombosis. |